# IGSF6

## Overview
IGSF6 is a gene that encodes the protein immunoglobulin superfamily member 6, which is a transmembrane protein predominantly expressed in immune-related tissues. This protein is part of the immunoglobulin superfamily and is involved in various immune processes, including antigen presentation and immune cell signaling. IGSF6 is located on the plasma membrane and is associated with the major histocompatibility complex (MHC), suggesting its role in facilitating interactions between immune cells and antigens. The protein is implicated in pathways related to phagosome formation and cell adhesion, which are essential for the uptake and processing of antigens by dendritic cells and macrophages. Additionally, IGSF6 is involved in cytokine signaling pathways that regulate immune cell function, and its expression is linked to immune cell proliferation and infiltration, particularly in the context of tumor microenvironments (Zheng2023Immunoglobulin; Zheng2023Immunoglobulina).

## Structure


## Function
IGSF6, or immunoglobulin superfamily member 6, is a protein primarily expressed in immune system tissues, including the spleen, lymph nodes, and peripheral blood lymphocytes, with lower expression in bone marrow, thymus, fetal liver, and appendix (Zheng2023Immunoglobulin; Zheng2023Immunoglobulina). It is located on the plasma membrane and is associated with the major histocompatibility complex (MHC), indicating its involvement in antigen presentation and immune response (Zheng2023Immunoglobulin; Zheng2023Immunoglobulina).

IGSF6 is thought to function as a co-receptor in antigen uptake or homing of dendritic cells (DCs), facilitating interactions and signaling essential for immune cell proliferation and antigen processing (Zheng2023Immunoglobulina). It is linked to phagosome formation and cell adhesion pathways, which are crucial for antigen uptake and presentation by DCs and macrophages (Zheng2023Immunoglobulina). The protein is involved in cytokine signaling pathways that regulate immune cell function, as evidenced by its correlation with cytokine-receptor interaction pathways (Zheng2023Immunoglobulina).

IGSF6 is also associated with the proliferation of mononuclear cells, particularly lymphocytes, suggesting its role in promoting immune cell proliferation within the tumor microenvironment (Zheng2023Immunoglobulina). Its expression correlates with increased infiltration of M1 macrophages, immature DCs, and Th1 cells, while negatively correlating with M2 macrophage infiltration, indicating a role in promoting anti-tumor activity (Zheng2023Immunoglobulina).

## Clinical Significance
Alterations in the expression of the IGSF6 gene have been implicated in various diseases, particularly in the context of cancer and immune-related disorders. In lung adenocarcinoma (LUAD), IGSF6 expression is significantly decreased, which is associated with increased methylation levels at its promoter. This downregulation correlates with poor prognosis, including reduced overall survival and progression-free intervals in patients. IGSF6 is linked to immune cell proliferation and antigen presentation, and its low expression is associated with decreased antitumor immune activity, particularly involving M1 macrophages and T helper 1 cells (Zheng2023Immunoglobulin; Zheng2023Immunoglobulina).

In colorectal cancer (CRC), particularly in mismatch repair-proficient cases, IGSF6 is more highly expressed in tumor tissues compared to normal tissues. High IGSF6 expression is associated with better responses to immunotherapy and chemotherapy, suggesting its role as a potential biomarker for therapeutic response. It is positively correlated with immune cell infiltration, including CD4+ and CD8+ T cells, and with immune checkpoints such as PD-1 and PD-L1, indicating an activated adaptive immune phenotype in tumors with high IGSF6 expression (Xu2023IGSF6; Rong2023IGSF6).

## Interactions



## References


[1. (Zheng2023Immunoglobulin) Qisi Zheng, Ting Wang, Gechen Jiang, Miao Li, Zhi Zhang, Yuxin Chen, and Xinyu Tian. Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma. BMC Cancer, November 2023. URL: http://dx.doi.org/10.1186/s12885-023-11681-w, doi:10.1186/s12885-023-11681-w. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-023-11681-w)

2. (Zheng2023Immunoglobulina) Immunoglobulin superfamily 6-mediated immune signature determines prognosis and immune landscape in lung adenocarcinoma. This article has 0 citations.

[3. (Rong2023IGSF6) Yu-ming Rong, Yu-cheng Xu, Xiao-chuan Chen, Min-er Zhong, Ying-xin Tan, Yu-fan Liang, Jing-rong Weng, Jun Liu, Xin-you Wang, Dan-dong Luo, Yi-ran Bie, Xi Chen, Jia-wei Cai, Zhao-liang Yu, and Yi-feng Zou. Igsf6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer. Scientific Reports, November 2023. URL: http://dx.doi.org/10.1038/s41598-023-47739-9, doi:10.1038/s41598-023-47739-9. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-47739-9)

4. (Xu2023IGSF6) IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer. This article has 0 citations.